Cutting-edge CAR-T cancer therapy is now made in India — at one-tenth the cost

Smriti Mallapaty

Nature, 2024, vol. 627, issue 8005, 709-710

Abstract: The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.

Keywords: Diseases; Medical research; Cancer (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-024-00809-y Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:627:y:2024:i:8005:d:10.1038_d41586-024-00809-y

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-024-00809-y

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().